🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07038499
Starting soon Observational

Prevalence and Determinants of Migraine Among Headache Patients

NCT07038499 · tracked via the Priya Life Science China tracker
Sponsor
Universiti Tunku Abdul Rahman
Phase
Observational
Started
2025-06-23
Last updated
2025-06-26

Condition(s) studied

Headache (Migraine)

Study summary

Migraine is a prevalent and disabling neurological condition that often coexists with other health issues, such as hypertension and impaired physical, mental, and social functioning. Understanding the prevalence of migraine and its associations with these health domains can provide valuable insights into the broader impact of migraine on overall well-being. By focusing on patients at the Affiliated Hospital of Hebei University of Engineering in China, this study can identify specific health burdens within this population, inform integrated clinical management strategies, and support the development of targeted interventions to improve patient outcomes and quality of life.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: • Patients diagnosed with headache according to the International Classification of Headache Disorders, 3rd Edition (ICHD-3). Exclusion Criteria: * Patients with other major diseases or severe mental disorders; * History of endocrine, immune, or nervous system diseases or other severe somatic diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Affiliated Hospital of Hebei University of Engineering, China Hebei China

More Universiti Tunku Abdul Rahman trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07038499 on ClinicalTrials.gov ↗ ← All trials in China